Prairiewood Capital’s Pediatrix Medical MD Stock Holding History

Prairiewood Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,721	Closed	-$233K	–	72
2021 Q2	$233K	Buy	+7,721	New	+$228K	0.2%	65

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Prairiewood Capital's MD Position: Q3 2021 in Review

Prairiewood Capital sold out of Pediatrix Medical (MD) in Q3 2021, closing a stake of 7,721 shares — an estimated $233K sold.

Prairiewood Capital first reported a position in MD in Q2 2021 and held it in 1 quarter. The position peaked at $233K in Q2 2021. 220 funds tracked by Wall St. Rank hold MD as of Q3 2021.

Prairiewood Capital reported no remaining Pediatrix Medical position as of Q3 2021 after selling out during the quarter.
Prairiewood Capital sold 7,721 Pediatrix Medical shares in Q3 2021, an estimated $233K.
Prairiewood Capital first reported a position in Pediatrix Medical in Q2 2021 and held it in 1 quarter.
Prairiewood Capital's Pediatrix Medical position peaked at $233K in Q2 2021.
220 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2021.

Based on Prairiewood Capital's 13F filing for Q3 2021, filed 13 Oct 2021.